Vioxx Settlement Funding, Vioxx Lawsuit Loans and Vioxx Class Action Suit

Vioxx Lawsuit Funding

Cases Eligible for Lawsuit Funding
picture
Vioxx Settlement Funding

Vioxx Settlement Loans
Vioxx Lawsuit Settlement 2011

Have a Vioxx Settlement Coming But Need Cash NOW? TriMark Legal Funding LLC Can Provide $500-$500,000 in 24-48 Hours on the Vioxx Lawsuit and Vioxx Class Action Suit. Fast Approvals, Bad Credit OK & Low Rates Guaranteed!

Interested in hearing what some of our past clients have to say about their experience with TriMark Legal Funding LLC?

Read Client Testimonials

>> Visit Our Blog <<

Vioxx Lawsuit Loans

Dozens of class action pharmaceutical lawsuits and dangerous drug lawsuits are currently pending in the United States. Millions of people have been maimed or permanently injured and tens of thousands more have been killed by the negligent, irresponsible and often unconscionable actions of big pharmaceutical companies.

What is Vioxx (Rofecoxib)?

Vioxx Lawsuit Loans

Vioxx (Rofecoxib) belongs to the nonsteroidal anti inflammatory class of drugs (NSAID). It works by reducing inflammation, pain and fever.

Vioxx Recall

Merck announced a voluntary worldwide Vioxx recall in 2004 when evidence began emerging that Vioxx significantly increased the risk of life-threatening cardiovascular events such as heart attack and stroke.

Pre Settlement Loans
Lawsuit loans (also called pre settlement loans or lawsuit cash advances) are available on personal injury lawsuits and can provide you with the cash you need, when you need it, to keep your family safe from financial hardships.

Helpful Resources:

Vioxx Class Action Lawsuit Funding Is Still Available

Vioxx Lawsuit Funding | Vioxx Lawsuit Loans | Vioxx Settlement Funding
Settlement Advances for Plaintiffs Seriously Injured By Vioxx Side Effects

Application
Please provide ALL information requested:

(xxx-xxx-xxxx)


Any Prior Advances?

NOTICE FOR WORKERS COMP CASES ONLY:
If you live in a state that is NOT on this Eligibility List, your application will be discarded.
Is This Workers Comp?




Failure to provide attorney's fax number WILL result in a lengthy processing delay!
Vioxx Lawsuit Loans

February 10, 2005
TriMark Legal Funding LLC announced that it will offer lawsuit advances on the Vioxx lawsuit.

Are you looking for lawsuit loans or lawsuit funding? If you are, TriMark Legal Funding LLC is one of the few lawsuit funding companies still offering settlement funding on Vioxx cases. The Merck Vioxx settlement will go down in history as one of the largest MDL (multi district litigation) pharmaceutical cases in American legal history.

In 2007, Merck agreed to a $4.85 billion settlement which it expects to resolve nearly 50,000 Vioxx lawsuits. The decision marked the beginning of the end of the four-year Vioxx legal fight, which started when Merck voluntarily removed Vioxx from the market in September 2004 after massive numbers of cardiovascular side effects began surfacing.

The Merck Legacy

Vioxx Lawsuit Loans

Merck & Co. holds a sinister and dubious record among drug giants; it currently holds the world record for the largest, most widespread and most reprehensible act of unbridled corporate greed and irresponsibility in the history of American pharmaceuticals. Why? Merck knowingly put profits before people; it stood by for 6 years and raked in tens of billions of dollars in profits while hundreds of thousands of people suffered strokes, heart attacks and/or died from Vioxx.

Merck possessed clear evidence prior to even receiving FDA approval to market Vioxx that it increased the risk of heart attack by almost 700%, but instead of doing the responsible thing and withdrawing or reformulating Vioxx, Merck took it to market anyway and reaped tens of billions of dollars in profit for six years. Merck finally withdrew the product in 2004 amid tens of thousands of deaths and a firestorm of litigation, but by then the catastrophic damage had already been done.

The obvious rationale was that Merck planned to offset the inevitable multi-billion dollar litigation expenses with the billions of dollars it earned by continuing to sell more of it's lethal product. Merck disclosed revenue for Vioxx' declining years at $2.5 billion in 2003 and $1.3 billion in 2004 before it was withdrawn. Merck has refused to disclose revenue from prior years except to acknowledge that Vioxx was one of it's best selling and most popular products ... EVER.

Merck and the Vioxx Debacle
28,000 Dead, 160,000 Injured and BILLIONS In Profits Earned By Merck

Vioxx Lawsuit Loans

In one estimate by the FDA, 140,000 personal injuries are attributable to Vioxx in the US alone, but no one knows for sure how many people have actually been injured from it.

World-renowned FDA scientist Dr. David Graham stunned the world with his incredible testimony against Vioxx and the FDA: Some excerpts include:

"Prior to [FDA] approval of Vioxx, a study was performed by Merck named 090. This study found nearly a 7-fold increase in heart attack risk with low dose Vioxx. The labeling at approval said nothing about heart attack risks. In November 2000, another Merck clinical trial named VIGOR found a 5-fold increase in heart attack risk with high-dose Vioxx."

"Dr. Eric Topol at the Cleveland Clinic recently estimated up to 160,000 cases of heart attacks and strokes due to Vioxx, in an article published in the New England Journal of Medicine."

"Today, in 2004, you, we, are faced with what may be the single greatest drug safety catastrophe in the history of this country or the history of the world. We are talking about a catastrophe that I strongly believe could have, should have been largely or completely avoided. But it wasn't, and over 100,000 Americans have paid dearly for this failure."

"The problem you are confronting today is immense in scope. Vioxx is a terrible tragedy and a profound regulatory failure. I would argue that the FDA, as currently configured, is incapable of protecting America against another Vioxx. We are virtually defenseless."

Vioxx Litigation & Merck Settlement

Vioxx Lawsuit Loans

Rofecoxib settlement amounts can range from a minimum of $5,000 up to several million dollars. Payments are determined by a complicated formula that factors in how serious a claimant's injury was, how much of the drug was taken and how many other risk factors the person had that might have contributed to, or aggravated, their injuries.

In the meantime, it is becoming commonplace for people who have been injured by, or who have lost a family member to, Vioxx to find themselves in need of extra money due to loss of income from being out of work (or loss of the primary breadwinner's income) to pay for bills, medical care and basic living expenses. Pre settlement funding or a lawsuit cash advance can give plaintiffs the money they need now to get by until their full settlement comes through, whenever that is.

Getting a lawsuit pre settlement funding advance is simple and easy as long as you have a legitimate Vioxx case with a sizable point award. A lawsuit cash advance is fast, free and easy to apply for and with no credit checks, no income or employment requirements, no monthly payments and no up-front or out-of-pocket costs, settlement loans and litigation funding is 100% RISK-FREE for plaintiffs and you only repay the advance if you win your case. If you lose your case or your case doesn't settle, YOU OWE US NOTHING!

VIOXX LAWSUIT SETTLEMENT FUNDING IS 100% RISK-FREE ... SO WHY WAIT?

Does your Vioxx lawsuit qualify for a legal cash advance? Call 1-877-932-2628 and find out or apply online!

Apply

We purchase structured settlements and/or provide lawsuit cash advance services for Vioxx lawsuits throughout the United States: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming and the District of Columbia (Washington DC).